Tenax, Amphastar, Arcturus: Why These 3 Pharma Stocks Are Moving

Tenax Therapeutics TENX shares were trading higher Tuesday after HC Wainwright & Co. initiated coverage of the stock with a Buy rating and $5 price target.  

Tenax Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs.

Tenax Therapeutics shares were up 94.39% at $2.08 at last check. The stock has a 52-week high of $2.84 and a 52-week low of 25 cents.

Amphastar AMPH shares were trading higher after the company announced the FDA has approved its abbreviated NDA for Glucagon for Injection Emergency Kit, 1 mg.

Amphastar Pharmaceuticals is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products.

Amphastar shares traded up 3.94% to $19.77. The stock has a 52-week high of $22.69 and a 52-week low of $12.32.

Arcturus Therapeutics ARCT shares were trading lower by 54.41% to $42.13 after the company provided an update on data on its coronavirus vaccine candidate ARCT-021. Following the update, multiple firms downgraded the stock.